Global and United States Olaparib Market Report & Forecast 2024-2031

Report ID: 1869252 | Published Date: Jan 2025 | No. of Page: 73 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Olaparib Product Introduction
    1.2 Global Olaparib Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Olaparib Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Olaparib Sales in Volume for the Year 2017-2028
    1.3 United States Olaparib Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Olaparib Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Olaparib Sales in Volume for the Year 2017-2028
    1.4 Olaparib Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Olaparib in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Olaparib Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Olaparib Market Dynamics
        1.5.1 Olaparib Industry Trends
        1.5.2 Olaparib Market Drivers
        1.5.3 Olaparib Market Challenges
        1.5.4 Olaparib Market Restraints
    1.6 Study Objectives
    1.7 Years Considered
2 Market by Type
    2.1 Olaparib Market Segment by Type
        2.1.1 Tablets
        2.1.2 Capsules
    2.2 Global Olaparib Market Size by Type
        2.2.1 Global Olaparib Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Olaparib Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Olaparib Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Olaparib Market Size by Type
        2.3.1 United States Olaparib Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Olaparib Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Olaparib Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
    3.1 Olaparib Market Segment by Application
        3.1.1 Ovarian Cancers
        3.1.2 Breast Cancers
        3.1.3 Prostate Cancers
        3.1.4 Other
    3.2 Global Olaparib Market Size by Application
        3.2.1 Global Olaparib Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Olaparib Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Olaparib Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Olaparib Market Size by Application
        3.3.1 United States Olaparib Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Olaparib Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Olaparib Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Olaparib Competitor Landscape by Company
    4.1 Global Olaparib Market Size by Company
        4.1.1 Top Global Olaparib Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Olaparib Revenue by Manufacturer (2017-2022)
        4.1.3 Global Olaparib Sales by Manufacturer (2017-2022)
        4.1.4 Global Olaparib Price by Manufacturer (2017-2022)
    4.2 Global Olaparib Concentration Ratio (CR)
        4.2.1 Olaparib Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Olaparib in 2021
        4.2.3 Global Olaparib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Olaparib Manufacturing Base Distribution, Product Type
        4.3.1 Global Olaparib Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Olaparib Product Type
        4.3.3 Date of International Manufacturers Enter into Olaparib Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Olaparib Market Size by Company
        4.5.1 Top Olaparib Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Olaparib Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Olaparib Sales by Players (2020, 2021 & 2022)
5 Global Olaparib Market Size by Region
    5.1 Global Olaparib Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Olaparib Market Size in Volume by Region (2017-2028)
        5.2.1 Global Olaparib Sales in Volume by Region: 2017-2022
        5.2.2 Global Olaparib Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Olaparib Market Size in Value by Region (2017-2028)
        5.3.1 Global Olaparib Sales in Value by Region: 2017-2022
        5.3.2 Global Olaparib Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Olaparib Market Size YoY Growth 2017-2028
        6.1.2 North America Olaparib Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Olaparib Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Olaparib Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Olaparib Market Size YoY Growth 2017-2028
        6.3.2 Europe Olaparib Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Olaparib Market Size YoY Growth 2017-2028
        6.4.2 Latin America Olaparib Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Olaparib Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Olaparib Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 AstraZeneca
        7.1.1 AstraZeneca Corporation Information
        7.1.2 AstraZeneca Description and Business Overview
        7.1.3 AstraZeneca Olaparib Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 AstraZeneca Olaparib Products Offered
        7.1.5 AstraZeneca Recent Development
    7.2 Everest Pharmaceuticals
        7.2.1 Everest Pharmaceuticals Corporation Information
        7.2.2 Everest Pharmaceuticals Description and Business Overview
        7.2.3 Everest Pharmaceuticals Olaparib Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 Everest Pharmaceuticals Olaparib Products Offered
        7.2.5 Everest Pharmaceuticals Recent Development
8 Industry Chain and Sales Channels Analysis
    8.1 Olaparib Industry Chain Analysis
    8.2 Olaparib Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Olaparib Distributors
    8.3 Olaparib Production Mode & Process
    8.4 Olaparib Sales and Marketing
        8.4.1 Olaparib Sales Channels
        8.4.2 Olaparib Distributors
    8.5 Olaparib Customers
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Olaparib CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Olaparib Market Trends
    Table 3. Olaparib Market Drivers
    Table 4. Olaparib Market Challenges
    Table 5. Olaparib Market Restraints
    Table 6. Global Olaparib Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Olaparib Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Olaparib Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Olaparib Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Olaparib Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Olaparib Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Olaparib Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Olaparib Sales by Manufacturer, (K Pcs), 2017-2022
    Table 14. Global Olaparib Sales Share by Manufacturer, 2017-2022
    Table 15. Global Olaparib Price by Manufacturer (2017-2022) & (USD/Pcs)
    Table 16. Global Olaparib Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Olaparib by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Olaparib as of 2021)
    Table 18. Top Players of Olaparib in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Olaparib Product Type
    Table 20. Date of International Manufacturers Enter into Olaparib Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Olaparib Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Olaparib Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Olaparib Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Olaparib Sales by Players, (K Pcs), 2020, 2021 & 2022
    Table 26. United States Olaparib Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Olaparib Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Olaparib Sales in Volume by Region (2017-2022) & (K Pcs)
    Table 29. Global Olaparib Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
    Table 30. Global Olaparib Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Olaparib Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Olaparib Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 33. North America Olaparib Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Olaparib Sales in Volume by Region (2017-2028) & (K Pcs)
    Table 35. Asia Pacific Olaparib Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Olaparib Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 37. Europe Olaparib Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Olaparib Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 39. Latin Americaa Olaparib Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Olaparib Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 41. Middle East and Africa Olaparib Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. AstraZeneca Corporation Information
    Table 43. AstraZeneca Description and Business Overview
    Table 44. AstraZeneca Olaparib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 45. AstraZeneca Olaparib Product
    Table 46. AstraZeneca Recent Development
    Table 47. Everest Pharmaceuticals Corporation Information
    Table 48. Everest Pharmaceuticals Description and Business Overview
    Table 49. Everest Pharmaceuticals Olaparib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 50. Everest Pharmaceuticals Product
    Table 51. Everest Pharmaceuticals Recent Development
    Table 52. Key Raw Materials Lists
    Table 53. Raw Materials Key Suppliers Lists
    Table 54. Olaparib Customers List
    Table 55. Olaparib Distributors List
    Table 56. Research Programs/Design for This Report
    Table 57. Key Data Information from Secondary Sources
    Table 58. Key Data Information from Primary Sources
List of Figures
    Figure 1. Olaparib Product Picture
    Figure 2. Global Olaparib Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Olaparib Market Size 2017-2028 (US$ Million)
    Figure 4. Global Olaparib Sales 2017-2028 (K Pcs)
    Figure 5. United States Olaparib Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Olaparib Market Size 2017-2028 (US$ Million)
    Figure 7. United States Olaparib Sales 2017-2028 (K Pcs)
    Figure 8. United States Olaparib Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Olaparib Market Share in Global, in Volume (K Pcs) 2017-2028
    Figure 10. Olaparib Report Years Considered
    Figure 11. Product Picture of Tablets
    Figure 12. Product Picture of Capsules
    Figure 13. Global Olaparib Market Share by Type in 2022 & 2028
    Figure 14. Global Olaparib Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Olaparib Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Olaparib Sales by Type (2017-2028) & (K Pcs)
    Figure 17. Global Olaparib Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Olaparib Price by Type (2017-2028) & (USD/Pcs)
    Figure 19. United States Olaparib Market Share by Type in 2022 & 2028
    Figure 20. United States Olaparib Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Olaparib Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Olaparib Sales by Type (2017-2028) & (K Pcs)
    Figure 23. United States Olaparib Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Olaparib Price by Type (2017-2028) & (USD/Pcs)
    Figure 25. Product Picture of Ovarian Cancers
    Figure 26. Product Picture of Breast Cancers
    Figure 27. Product Picture of Prostate Cancers
    Figure 28. Product Picture of Other
    Figure 29. Global Olaparib Market Share by Application in 2022 & 2028
    Figure 30. Global Olaparib Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 31. Global Olaparib Sales Market Share in Value by Application (2017-2028)
    Figure 32. Global Olaparib Sales by Application (2017-2028) & (K Pcs)
    Figure 33. Global Olaparib Sales Market Share in Volume by Application (2017-2028)
    Figure 34. Global Olaparib Price by Application (2017-2028) & (USD/Pcs)
    Figure 35. United States Olaparib Market Share by Application in 2022 & 2028
    Figure 36. United States Olaparib Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 37. United States Olaparib Sales Market Share in Value by Application (2017-2028)
    Figure 38. United States Olaparib Sales by Application (2017-2028) & (K Pcs)
    Figure 39. United States Olaparib Sales Market Share in Volume by Application (2017-2028)
    Figure 40. United States Olaparib Price by Application (2017-2028) & (USD/Pcs)
    Figure 41. North America Olaparib Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 42. North America Olaparib Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 43. U.S. Olaparib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Canada Olaparib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Europe Olaparib Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 46. Europe Olaparib Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 47. Germany Olaparib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. France Olaparib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. U.K. Olaparib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Italy Olaparib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Russia Olaparib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Asia-Pacific Olaparib Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 53. Asia-Pacific Olaparib Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 54. China Olaparib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Japan Olaparib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. South Korea Olaparib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. India Olaparib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Australia Olaparib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Taiwan Olaparib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Indonesia Olaparib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Thailand Olaparib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Malaysia Olaparib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Philippines Olaparib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Latin America Olaparib Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 65. Latin America Olaparib Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 66. Mexico Olaparib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Brazil Olaparib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Argentina Olaparib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Middle East & Africa Olaparib Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 70. Middle East & Africa Olaparib Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 71. Turkey Olaparib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Saudi Arabia Olaparib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. U.A.E Olaparib Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Olaparib Value Chain
    Figure 75. Olaparib Production Process
    Figure 76. Channels of Distribution
    Figure 77. Distributors Profiles
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AstraZeneca
Everest Pharmaceuticals
Frequently Asked Questions
Olaparib report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Olaparib report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Olaparib report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Carfilzomib

Carfilzomib market is segmented by region (country), players, by Type and by Application. Players ... Read More

Melphalan

Melphalan market is segmented by region (country), players, by Type and by Application. Players,  ... Read More

Exemestane

Exemestane market is segmented by region (country), players, by Type and by Application. Players, ... Read More